CHRNA9

From Wikipedia, the free encyclopedia
Jump to: navigation, search
CHRNA9
Available structures
PDB Human UniProt search: PDBe RCSB
Identifiers
Aliases CHRNA9, HSA243342, NACHRA9, cholinergic receptor nicotinic alpha 9 subunit
External IDs MGI: 1202403 HomoloGene: 9729 GeneCards: CHRNA9
Targeted by Drug
muscarine[1]
RNA expression pattern
PBB GE CHRNA9 221107 at fs.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_017581

NM_001081104

RefSeq (protein)

NP_060051

n/a

Location (UCSC) Chr 4: 40.34 – 40.36 Mb Chr 5: 65.93 – 65.98 Mb
PubMed search [2] [3]
Wikidata
View/Edit Human View/Edit Mouse

Neuronal acetylcholine receptor subunit alpha-9, also known as nAChRα9, is a protein that in humans is encoded by the CHRNA9 gene.[4] The protein encoded by this gene is a subunit of certain nicotinic acetylcholine receptors (nAchR).

This gene is a member of the ligand-gated ionic channel family and nicotinic acetylcholine receptor gene superfamily. It encodes a plasma membrane protein that forms homo- or hetero-oligomeric divalent cation channels. This protein is involved in cochlea hair cell development and is also expressed in the outer hair cells (OHCs) of the adult cochlea. The protein is additionally expressed in keratinocytes, the pituitary gland, B-cells and T-cells.[4]

Selective block of α9α10 nicotinic acetylcholine receptors by the conotoxin RgIA has been shown to be analgesic in an animal model of nerve injury pain.[5]

See also[edit]

References[edit]

Further reading[edit]

External links[edit]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.